Credit Suisse’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-131,712
Closed -$8.97M 4231
2022
Q3
$8.97M Buy
131,712
+78,996
+150% +$5.38M 0.01% 957
2022
Q2
$1.68M Sell
52,716
-5,706
-10% -$182K ﹤0.01% 2022
2022
Q1
$2.02M Buy
58,422
+3,989
+7% +$138K ﹤0.01% 2055
2021
Q4
$1.59M Sell
54,433
-2,014
-4% -$58.9K ﹤0.01% 2291
2021
Q3
$1.44M Buy
56,447
+3,076
+6% +$78.4K ﹤0.01% 2354
2021
Q2
$1.87M Sell
53,371
-11,089
-17% -$389K ﹤0.01% 2237
2021
Q1
$2.63M Sell
64,460
-22,602
-26% -$921K ﹤0.01% 1972
2020
Q4
$3.77M Buy
87,062
+815
+0.9% +$35.3K ﹤0.01% 1717
2020
Q3
$4.76M Buy
86,247
+2,845
+3% +$157K ﹤0.01% 1317
2020
Q2
$5.27M Buy
83,402
+25,784
+45% +$1.63M ﹤0.01% 1277
2020
Q1
$2.94M Sell
57,618
-25,364
-31% -$1.3M ﹤0.01% 1435
2019
Q4
$6.6M Buy
82,982
+38,258
+86% +$3.04M ﹤0.01% 1266
2019
Q3
$2.17M Sell
44,724
-157,013
-78% -$7.62M ﹤0.01% 1872
2019
Q2
$10.6M Buy
201,737
+164,987
+449% +$8.68M 0.01% 971
2019
Q1
$1.94M Sell
36,750
-137
-0.4% -$7.25K ﹤0.01% 1915
2018
Q4
$1.52M Sell
36,887
-10,422
-22% -$428K ﹤0.01% 1994
2018
Q3
$1.8M Sell
47,309
-4,861
-9% -$185K ﹤0.01% 2018
2018
Q2
$2.36M Sell
52,170
-4,541
-8% -$205K ﹤0.01% 1952
2018
Q1
$2.74M Buy
56,711
+20,113
+55% +$971K ﹤0.01% 1832
2017
Q4
$1.44M Sell
36,598
-77,647
-68% -$3.06M ﹤0.01% 2280
2017
Q3
$3.55M Buy
114,245
+4,549
+4% +$141K ﹤0.01% 1696
2017
Q2
$3M Buy
109,696
+18,581
+20% +$508K ﹤0.01% 1659
2017
Q1
$3.36M Sell
91,115
-2,461
-3% -$90.7K ﹤0.01% 1664
2016
Q4
$1.35M Buy
93,576
+77,159
+470% +$1.11M ﹤0.01% 2462
2016
Q3
$379K Sell
16,417
-14,922
-48% -$344K ﹤0.01% 3224
2016
Q2
$519K Buy
31,339
+12,968
+71% +$215K ﹤0.01% 3107
2016
Q1
$291K Buy
18,371
+11,700
+175% +$185K ﹤0.01% 3227
2015
Q4
$215K Sell
6,671
-8,300
-55% -$268K ﹤0.01% 3623
2015
Q3
$631K Buy
+14,971
New +$631K ﹤0.01% 3029